Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2238)
All Articles published online
|
Nov 28, 2007 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El Haj M, Ya'acov AB, Lalazar G, Ilan Y. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. World J Gastroenterol 2007; 13(44): 5799-5804 [PMID: 17990345 DOI: 10.3748/wjg.v13.i44.5799] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5799.htm |
| Number | Citing Articles |
| 1 |
Ying Liu, Qiang Shu, Lifen Gao, Nan Hou, Di Zhao, Xiao Liu, Xiaoning Zhang, Liyun Xu, Xuetian Yue, Faliang Zhu, Chun Guo, Xiaohong Liang, Chunhong Ma. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clinical Immunology 2010; 137(2): 288 doi: 10.1016/j.clim.2010.07.012
|
| 2 |
Yaron Ilan, Ami Ben Ya'acov, Yehudit Shabbat, Svetlana Gingis-Velitski, Einat Almon, Yoseph Shaaltiel. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis. World Journal of Gastroenterology 2016; 22(39): 8760-8769 doi: 10.3748/wjg.v22.i39.8760
|
| 3 |
Tomer Adar, Ravi Shankar Lankalapalli, Robert Bittman, Yaron Ilan. The assembly of glycosphingolipid determines their immunomodulatory effect: A novel method for structure-based design of immunotherapy. Cellular Immunology 2020; 355: 104157 doi: 10.1016/j.cellimm.2020.104157
|
| 4 |
Yaron Ilan. β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01143
|
| 5 |
Einat Almon, Tawfik Khoury, Ariel Drori, Svetlana Gingis-Velitski, Sari Alon, Raul Chertkoff, Mordechai Mushkat, Yoseph Shaaltiel, Yaron Ilan. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. Journal of Immunological Methods 2017; 446: 21 doi: 10.1016/j.jim.2017.03.023
|
| 6 |
Meir Mizrahi, Tomer Adar, Gadi Lalazar, Dean Nachman, Madi El Haj, Ami Ben Ya’acov, Yoav Lichtenstein, Yehudit Shabat, Dimitri Kanovich, Lida Zolotarov, Yaron Ilan. Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00071
|
| 7 |
Tahel Ilan-Ber, Yaron Ilan. The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. Molecular Immunology 2019; 111: 73 doi: 10.1016/j.molimm.2019.04.014
|
| 8 |
Jana Šímová, Marie Indrová, Jana Bieblová, Romana Mikyšková, Jan Bubeník, Milan Reiniš. Therapy for minimal residual tumor disease: β‐Galactosylceramide inhibits the growth of recurrent HPV16‐associated neoplasms after surgery and chemotherapy. International Journal of Cancer 2010; 126(12): 2997 doi: 10.1002/ijc.24887
|
| 9 |
Yuval Ishay, Ari Zimran, Jeffrey Szer, Tama Dinur, Yaron Ilan, David Arkadir. Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development. Blood Cells, Molecules, and Diseases 2018; 68: 117 doi: 10.1016/j.bcmd.2016.10.028
|
| 10 |
Tawfik Khoury, Yuval Ishay, Devorah Rotnemer-Golinkin, Lidya Zolotarovya, David Arkadir, Ari Zimran, Yaron Ilan. A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders. Biomedicine & Pharmacotherapy 2020; 132: 110890 doi: 10.1016/j.biopha.2020.110890
|
| 11 |
Chansu Lee, Sung Noh Hong, Young-Ho Kim. A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells. Intestinal Research 2020; 18(4): 402 doi: 10.5217/ir.2019.00132
|
| 12 |
Eran Israeli, Ehud Zigmond, Gadi Lalazar, Athalia Klein, Nilla Hemed, Eran Goldin, Yaron Ilan. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World Journal of Gastroenterology 2015; 21(18): 5685-5694 doi: 10.3748/wjg.v21.i18.5685
|
| 13 |
Eran Israeli, Yaron Ilan. Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease. Therapeutic Advances in Gastroenterology 2010; 3(1): 23 doi: 10.1177/1756283X09351733
|